Sign Up to like & get recommendations! 1
Published in 2022 at "JAMA cardiology"
DOI: 10.1001/jamacardio.2021.5244
Abstract: Importance Clopidogrel monotherapy after short dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) has not yet been fully investigated in patients with acute coronary syndrome (ACS). Objective To test the hypothesis of noninferiority of… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Brain and Behavior"
DOI: 10.1002/brb3.2664
Abstract: Previous studies suggest the benefit of dual antiplatelet therapy (DAPT) for acute ischemic stroke with large artery atherosclerosis (LAA) etiology, but there is no study about the effect of DAPT plus anticoagulant in this population. read more here.
Sign Up to like & get recommendations! 1
Published in 2023 at "Brain and Behavior"
DOI: 10.1002/brb3.2982
Abstract: The related factors affecting the adherence of ischemic cerebral stroke (ICS) patients to antiplatelet therapy have attracted much attention. read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.26653
Abstract: Whether the efficacy and safety of dual antiplatelet therapy (DAPT) are uniform between sexes is unclear. We sought to compare clinical outcomes between short‐ (≤6 months) versus long‐term (≥1 year) DAPT after drug‐eluting stent (DES)… read more here.
Sign Up to like & get recommendations! 1
Published in 2017 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.26948
Abstract: The optimal duration of dual antiplatelet therapy (DAPT) after drug‐eluting stent (DES) implantation remains undetermined, especially for those at high risk of cardiac events postprocedure. read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.28653
Abstract: To investigate the optimal dual antiplatelet therapy (DAPT) duration for diabetic patients with acute coronary syndrome (ACS) after percutaneous coronary intervention (PCI). read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.29411
Abstract: Ischemic and bleeding events portend equivalently poor prognosis after percutaneous coronary intervention (PCI). Risk factors for these untoward events largely overlap limiting the “decoupling” of bleeding and ischemic risk. While individual patient risk scores inform… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30467
Abstract: The American Heart Association/American College of Cardiology guidelines on dual antiplatelet therapy (DAPT) recommend at least 12 months of a P2Y12 inhibitor and low dose aspirin in patients with an acute coronary syndrome (ACS) treated… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30521
Abstract: The optimal dual antiplatelet therapy (DAPT) duration and regimen in patients undergoing percutaneous coronary intervention (PCI) using current generation drug eluting stents (DES) is still unclear. read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Herz"
DOI: 10.1007/s00059-019-4811-x
Abstract: Dual antiplatelet therapy (DAPT) is the cornerstone of maintenance medication following elective percutaneous coronary intervention and also after acute coronary syndrome (ST-elevation myocardial infarction, non-ST-elevation myocardial infarction, unstable angina pectoris); however, DAPT is not sufficient… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Graefe's Archive for Clinical and Experimental Ophthalmology"
DOI: 10.1007/s00417-018-4151-1
Abstract: Dear editor, I read with great interest the distinguished article by Meillon et al. BAntiplatelet and anticoagulant agents in vitreoretinal surgery: a prospective multicenter study involving 804 patients^ [1]. The authors concluded that these drugs… read more here.